Exposure to epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) treatment increased miR-1 expression in patients with lung adenocarcinoma (LUAD) (50). The gene discussed is EGFR; the disease is lung adenocarcinoma.